Jazz Pharmaceuticals
S&P 400
$245.80
+2.21%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Current assets comfortably cover current liabilities (current ratio 1.86).
!Watch-points
- Higher leverage: debt-to-equity of 1.12 is above 1.
- Return on equity is on the lower side at -7.4%.
- Return on capital employed is on the lower side at -4.9%.
- The company reported a net loss in the latest period.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Piotroski F-ScoreModerate
4 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$15.96B
Current Price$ 245.80
High / Low$ 266.38 / 123.88
Stock P/E16.835617
Book Value$ 69.19
Dividend Yield0%
ROCE-4.87%
ROE-7.42%
Debt to Equity1.12
Current Ratio1.86
P/B Ratio3.3171391
EPS$ -5.84
Debt$5.36B
PAT Margin-8.35%
Cash PAT$-314.55M